Clinical Trials Insight: 700030186
Phase of Trial: Phase I
Latest Information Update: 09 Jul 2008
At a glance
- Drugs Senicapoc (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors Neusentis
- 09 Jul 2008 Positive tolerability results reported in an Icagen media release.
- 09 Jul 2008 Status changed from recruiting to completed, as reported in an Icagen media release.
- 30 Jan 2008 New trial record.